BioMarin to Participate in Upcoming Investor Conferences
BioMarin Pharmaceutical (NASDAQ: BMRN) has announced its participation in three major healthcare investor conferences in September 2025:
- Cantor Global Healthcare Conference on September 3 at 8:00 AM EST
- Wells Fargo Healthcare Conference on September 4 at 8:45 AM EST
- Morgan Stanley Global Healthcare Conference on September 9 at 11:30 AM EST
The company will provide live audio webcasts of the presentations through their investor relations website, with archived versions available for limited time after each event.
BioMarin Pharmaceutical (NASDAQ: BMRN) parteciperà a tre importanti conferenze per investitori nel settore sanitario a settembre 2025:
- Cantor Global Healthcare Conference il 3 settembre alle 8:00 AM EST
- Wells Fargo Healthcare Conference il 4 settembre alle 8:45 AM EST
- Morgan Stanley Global Healthcare Conference il 9 settembre alle 11:30 AM EST
Le presentazioni saranno trasmesse in diretta audio via webcast sul sito web per gli investitori della società; le registrazioni saranno disponibili in archivio per un periodo limitato dopo ogni evento.
BioMarin Pharmaceutical (NASDAQ: BMRN) participará en tres importantes conferencias para inversores del sector sanitario en septiembre de 2025:
- Cantor Global Healthcare Conference el 3 de septiembre a las 8:00 AM EST
- Wells Fargo Healthcare Conference el 4 de septiembre a las 8:45 AM EST
- Morgan Stanley Global Healthcare Conference el 9 de septiembre a las 11:30 AM EST
La compañía ofrecerá retransmisiones de audio en directo de las presentaciones a través de su sitio web de relaciones con inversores; las grabaciones quedarán archivadas durante un tiempo limitado tras cada evento.
BioMarin Pharmaceutical (NASDAQ: BMRN)는 2025년 9월에 열리는 세 곳의 주요 헬스케어 투자자 컨퍼런스에 참석할 예정입니다:
- Cantor Global Healthcare Conference — 9월 3일 오전 8:00 EST
- Wells Fargo Healthcare Conference — 9월 4일 오전 8:45 EST
- Morgan Stanley Global Healthcare Conference — 9월 9일 오전 11:30 EST
회사 웹사이트의 투자자 관계 페이지를 통해 프레젠테이션을 실시간 오디오 웹캐스트로 제공하며, 각 이벤트 후 일정 기간 동안 아카이브 녹화도 볼 수 있습니다.
BioMarin Pharmaceutical (NASDAQ: BMRN) participera à trois grandes conférences investisseurs dans le secteur de la santé en septembre 2025 :
- Cantor Global Healthcare Conference le 3 septembre à 8:00 AM EST
- Wells Fargo Healthcare Conference le 4 septembre à 8:45 AM EST
- Morgan Stanley Global Healthcare Conference le 9 septembre à 11:30 AM EST
La société diffusera les présentations en direct sous forme de webcasts audio sur son site relations investisseurs ; des versions archivées seront disponibles pendant une durée limitée après chaque événement.
BioMarin Pharmaceutical (NASDAQ: BMRN) wird im September 2025 an drei großen Investorenkonferenzen im Gesundheitswesen teilnehmen:
- Cantor Global Healthcare Conference am 3. September um 8:00 AM EST
- Wells Fargo Healthcare Conference am 4. September um 8:45 AM EST
- Morgan Stanley Global Healthcare Conference am 9. September um 11:30 AM EST
Die Präsentationen werden als Live-Audio-Webcasts über die Investor-Relations-Website des Unternehmens übertragen; Aufzeichnungen stehen nach den Veranstaltungen für begrenzte Zeit im Archiv zur Verfügung.
- None.
- None.
- Cantor Global Healthcare Conference, September 3 at 8:00 am EST
- Wells Fargo Healthcare Conference, September 4 at 8:45 am EST
- Morgan Stanley Global Healthcare Conference, September 9 at 11:30 am EST
An audio webcast of the presentation will be available live. You can access the webcast at: https://investors.biomarin.com/. An archived version of the remarks will also be available through the Company's website for a limited time following the conference.
About BioMarin
BioMarin is a global biotechnology company dedicated to translating the promise of genetic discovery into medicines that make a profound impact on the life of each patient. The San Rafael,
Contacts: | |
Investors | Media |
Traci McCarty | Marni Kottle |
BioMarin Pharmaceutical Inc. | BioMarin Pharmaceutical Inc. |
(415) 455-7558 | (650) 374-2803 |
View original content to download multimedia:https://www.prnewswire.com/news-releases/biomarin-to-participate-in-upcoming-investor-conferences-302539513.html
SOURCE BioMarin Pharmaceutical Inc.